arrow
O

Olaf Tyc

goethe university frankfurt
H指数:19
被引数:1,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose study

安全性、药代动力学及VS-01(一种腹腔内脂质体输注)在失代偿期肝硬化、腹水及隐匿性肝性脑病患者的初步疗效:一项1b期、首次人体、开放标签、非随机化、单次及多次递增剂量研究

2026-02-170
OAAI
Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction

屎肠球菌DNA在急性失代偿性肝硬化中的作用:炎症和肾功能不全的关键因素

2025-10-200
OAAI
Enhanced surface colonisation and competition during bacterial adaptation to a fungus

细菌适应真菌过程中增强的表面定植和竞争

2024-05-273
OAAI
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
2023-02-017
OAAI
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
2022-10-1310
OAAI
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
2021-08-1319
OAAI
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
2020-10-0713
OAAI
Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development
2020-08-2818
OAAI